TerrAscend Stock (CSE: TER) (OTCQX: TRSSF) - Investor Dashboard

➔ TerrAscend
CSE Ticker: TER
Market Focus: Global
Classification: Vertical Integration
Country: Canada
Employees: 500+ as of 11/2019
Established: 2014
CEO: Jason Ackerman


Fiscal Year-End: December
Facilities: 2
Dried Flower: Production and Sale
Extracts: Production and Sale
Number of Patients: N/A
Headquarters: Mississauga, ON

Financials (06/30/20)

Cash on hand: C$69.7 million
Fixed Investment: C$148.7 million
Shareholders’ Equity: C$119.7 million
Revenues – Last Quarter: C$47.2 million
Adj. Gross Margin : 56.0%
EPS : -C$0.09

Capital Structure (08/20/20)

Last Financing: US$37 million Convertible Preferred
As-Converted Shares: 188.2 million
Warrants: 66.5 million
Options: 15.8 million
Diluted Shares:  289.0 million

Company Brief

TerrAscend provides quality products, brands, and services to the global cannabinoid market. As the first North American Operator (NAO), with scale operations in both Canada and the US, the Company participates in the medical and legal adult use market across Canada and in several US states where cannabis has been legalized for therapeutic or adult use.

Additionally, TerrAscend is the first and only cannabis company with sales in Europe as well as the US and Canada as it has received EU GMP certification for its manufacturing facility in Mississauga, Ontario.


  • Multi-state operator in the U.S.; nationwide distributor of hemp-derived CBD products; Canadian LP with global distribution; and drug development and R&D platform
  • Management comprised of leaders from healthcare, pharmaceutical, banking, cannabis, online grocery industries and CPG
  • Strategic investors include Canopy Growth, Canopy Rivers, and JW Funds
  • $80.5 million loan from strategic partner Canopy Growth
  • Unique ability to sell THC and CBD products within Canada and the U.S.through TerrAscend’s manufacturing footprint
  • Brand portfolio including premium cannabis Haven St., Valhalla Premium Edibles, Funky Farms CBD Extracts, Original Hemp, State Flower, and Ilera

Growth Strategy

  • Multi-state operator (MSO) in the U.S. focused on key markets: Pennsylvania, New Jersey and California
  • Canadian LP concentrating on production and manufacturing of cannabinoid products for medical and adult-use consumers
  • Focus on developing protectable intellectual property assets
  • Creating quality brands that resonate with patients and consumers
  • Plans to leverage The Apothecarium Dispensary brand and store model across the U.S.
  • U.S. nationwide distribution of hemp-derived CBD products through Arise Bioscience; access to 10,000+ stores


  • Proven consolidator with M&A expertise in the highly fragmented U.S. cannabis industry
  • First operator with scaled operations in both the U.S. and Canada
  • One of 12 vertically integrated entities in New Jersey; ability for 240,000 square feet of production and cultivation space and three retail licenses
  • Top wholesale market share in Pennsylvania’s limited license market via Ilera Healthcare; 144,000 square feet of production and cultivation space and three open dispensaries
  • 20,000 square feet of cultivation and production space, five retail licenses and four open dispensaries in California market

Institutional Analyst Coverage

Glenn. G. Mattson
Ladenburg Thalmann

Eric Des Lauriers, CFA
Craig-Hallum Capital Group

Noel Atkinson
Clarus Securities

Kenric S. Tyghe
AltaCorp Capital

Matt McGinley

Curated Stories & News

Visit TerrAscend, Inc.
at www.terrascend.com.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. TerrAscend, Inc. is a client of NCV Media, LLC. Read our full disclaimer.